Johnson & Johnson buy Finanzus
Start price
13.10.20
/
50%
€126.58
Target price
04.11.21
-
Performance (%)
12.20%
End price
05.11.21
€142.02
Summary
This prediction ended on 05.11.21 with a price of €142.02. The BUY prediction by Finanzus finished with a performance of 12.20%. A total of €3.45 was paid as dividends for this prediction. Finanzus has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | -2.961% | -2.961% | -10.455% | 0.162% |
| iShares Core DAX® | -1.785% | -1.250% | 11.664% | 12.714% |
| iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% | 41.653% |
| iShares Nikkei 225® | -4.028% | -3.746% | 17.142% | 0.393% |
| iShares S&P 500 | -1.969% | 0.307% | 25.617% | 40.084% |
Comments by Finanzus for this prediction
In the thread Johnson & Johnson diskutieren
Buy Johnson & Johnson
In the thread Trading Johnson & Johnson
Die von Finanzus gewählte maximale Laufzeit wurde überschritten